People: Myriad Genetics Inc (MYGN.O)

MYGN.O on Nasdaq

31.43USD
24 May 2013
Price Change (% chg)

$-0.76 (-2.36%)
Prev Close
$32.19
Open
$32.02
Day's High
$32.02
Day's Low
$31.02
Volume
1,104,565
Avg. Vol
1,178,079
52-wk High
$34.70
52-wk Low
$22.02

Search Stocks

Lanchbury, Jerry 

Brief Biography

Dr. Jerry S. Lanchbury, Ph.D., is Chief Scientific Officer of Myriad Genetics, Inc., since February 02, 2010. He joined the Company in September 2002 as Senior Vice President of Research. In July 2005 he was appointed Executive Vice President of Research, a position he held until he was named Chief Scientific Officer in February 2010. Dr. Lanchbury came to the Company from GKT School of Medicine, King’s College where he had served as Reader in Molecular Immunogenetics and Head of Molecular Immunogenetics Unit since 1997. Dr. Lanchbury earned his Ph.D. from the University of Newcastle upon Tyne and 1st Class Honours, B.Sc. “Biology of Man & his Environment” degree from the University of Aston.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
665,573 -- 1,218,130 1,883,710

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised 51,804 815,073.00
Name Fiscal Year Total

John Henderson

--

Peter Meldrum

5,951,710

Walter Gilbert

--

James Evans

2,175,360

T. Craig Benson

--

Mark Capone

2,894,360
As Of 29 Jun 2012
Search Stocks